My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Aera Therapeutics

Aera Therapeutics Presents Preclinical Data and Announces Nomination of First Development Candidate, AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases
From Aera Therapeutics
Via Business Wire
Aera Therapeutics Appoints Bill Querbes, Ph.D., as Chief Scientific Officer
From Aera Therapeutics
Via Business Wire
Aera Therapeutics Appoints Paul Conrad, Ph.D., MBA, as Chief Business and Financial Officer
From Aera Therapeutics
Via Business Wire
Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines
From Aera Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.